F Sato-Kaneko, S Yao, A Ahmadi, SS Zhang… - JCI insight, 2017 - ncbi.nlm.nih.gov
Checkpoint inhibitors have demonstrated efficacy in patients with recurrent or metastatic
head and neck squamous cell carcinoma (HNSCC). However, the majority of patients do not …